Merit Medical Systems Inc earnings per share and revenue
On Oct 30, 2025, MMSI reported earnings of 0.92 USD per share (EPS) for Q3 25, beating the estimate of 0.84 USD, resulting in a 8.41% surprise. Revenue reached 384.16 million, compared to an expected 379.35 million, with a 1.27% difference. The market reacted with a +5.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analysts forecast an EPS of 0.97 USD, with revenue projected to reach 397.46 million USD, implying an increase of 5.43% EPS, and increase of 3.46% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
McKesson Corporation
Report Date
Feb 04, 2026 For Q3 26
Estimate
$9.30
Actual
$9.34
Surprise
+0.33%
Cardinal Health, Inc.
Report Date
Feb 05, 2026 For Q2 26
Estimate
$2.37
Actual
$2.63
Surprise
+10.57%
Align Technology Inc
Report Date
Feb 04, 2026 For Q4 25
Estimate
$3.03
Actual
$3.29
Surprise
+8.55%
CONMED Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$1.34
Actual
$1.43
Surprise
+5.94%
Pro-Dex Inc New
Report Date
Jan 29, 2026 For Q2 26
Estimate
$0.60
Actual
$0.66
Surprise
+9.67%
Lifevantage Corporation Common Stock (Delaware)
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.15
Actual
$0.15
Surprise
-1.96%
FAQ
What were Merit Medical Systems Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Merit Medical Systems Inc reported EPS of $0.92, beating estimates by 8.41%, and revenue of $384.16M, 1.27% above expectations.
How did the market react to Merit Medical Systems Inc's Q3 2025 earnings?
The stock price moved up 5.42%, changed from $83.04 before the earnings release to $87.54 the day after.
When is Merit Medical Systems Inc expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Merit Medical Systems Inc's next earnings report?
Based on 13
analysts, Merit Medical Systems Inc is expected to report EPS of $0.97 and revenue of $397.46M for Q4 2025.